Related Experiment Video
Updated: Aug 2, 2026
07:41
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Rashkind and Clamshell Device Closure of Ventricular Septal Defect
1Department of Cardiology, Royal Children's Hospital, Flemington Road, Parkville 3052, Victoria, Melbourne, Australia. gohibm@cryptic.rch.unimelb.edu.au
Current Interventional Cardiology Reports
|November 7, 2001
Summary
This study reviews global experiences with transcatheter and intraoperative closure of ventricular septal defects (VSDs) using specialized devices. It details device descriptions, techniques, and personal insights for VSD treatment.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Medical Device Technology
Background:
- Ventricular septal defects (VSDs) are common congenital heart abnormalities requiring closure.
- Transcatheter and intraoperative closure offer alternative treatment modalities to traditional surgery.
- The Rashkind and Clamshell devices represent key innovations in VSD closure.
Purpose of the Study:
- To present a comprehensive overview of worldwide experience with VSD closure using Rashkind and Clamshell devices.
- To share personal insights and communications regarding the application of these devices.
- To provide detailed technical information on device deployment for VSD treatment.
Main Methods:
- Review of global clinical experience with transcatheter and intraoperative VSD closure.
- Inclusion of author's personal case experience and communications.
- Detailed description and illustration of devices, catheters, and deployment techniques.
Main Results:
- Summarizes worldwide experience in transcatheter and intraoperative VSD closure.
- Highlights the application and outcomes of Rashkind and Clamshell devices.
- Documents various techniques and modifications for device deployment.
Conclusions:
- Transcatheter and intraoperative VSD closure with Rashkind and Clamshell devices have established worldwide experience.
- Detailed technical understanding and procedural modifications are crucial for successful device deployment.
- This report serves as a valuable resource for clinicians involved in VSD management.
Related Concept Videos
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...